Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows provided by: | ||||||||||||||||||||||||||||||||
operating activities: | ||||||||||||||||||||||||||||||||
net income | 181,000,000 | 184,400,000 | 116,000,000 | 121,500,000 | 50,000,000 | 133,500,000 | 140,600,000 | 144,300,000 | 86,000,000 | 100,400,000 | 96,000,000 | 274,499,806.7 | 141.8 | -7.1 | 58.6 | 614,499,511 | 200.1 | 141.2 | 147.7 | 182,600,015.8 | 137.1 | 132.3 | -285.2 | 445,699,674.7 | 113.1 | -99,899,787.8 | 99,900,000 | 100,800,000 | 105,100,000 | 130,500,000 | 163,200,000 | 102,200,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||||
depreciation and amortization | 9,400,000 | 8,500,000 | 8,500,000 | 8,600,000 | 5,500,000 | 5,300,000 | 5,100,000 | 4,900,000 | 5,800,000 | 6,100,000 | 6,100,000 | 15,000,000 | 17,800,000 | 20,800,000 | 15,800,000 | 15,400,000 | 14,800,000 | |||||||||||||||
deferred income taxes | -300,000 | 2,100,000 | 500,000 | -1,500,000 | 1,300,000 | -900,000 | -6,200,000 | 0 | 1,000,000 | 400,000 | ||||||||||||||||||||||
stock-based compensation plan expense | 21,700,000 | 18,200,000 | 18,700,000 | 20,400,000 | 18,100,000 | 15,700,000 | 17,500,000 | 17,600,000 | 16,900,000 | 21,300,000 | 21,600,000 | 20,100,000 | 17,900,000 | 23,300,000 | 24,800,000 | 16,400,000 | ||||||||||||||||
reclassification of foreign currency translation to net income | 400,000 | 42,700,000 | 111,900,000 | |||||||||||||||||||||||||||||
investment gains | -55,100,000 | -35,000,000 | -6,400,000 | -22,500,000 | 16,600,000 | 700,000 | ||||||||||||||||||||||||||
other | 7,300,000 | -5,000,000 | -4,200,000 | -4,200,000 | -2,400,000 | -2,600,000 | -1,900,000 | -1,700,000 | -1,500,000 | -1,100,000 | -1,400,000 | -3,200,000 | ||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||||||||||||
oeic and unit trust receivables and payables | 700,000 | -1,900,000 | -6,100,000 | 700,000 | -600,000 | -1,600,000 | 4,500,000 | -2,700,000 | -800,000 | 11,100,000 | 500,000 | 2,300,000 | ||||||||||||||||||||
other assets | -28,100,000 | -28,200,000 | 87,200,000 | -57,900,000 | -24,800,000 | 24,000,000 | 46,500,000 | -74,800,000 | 34,600,000 | 37,100,000 | -22,100,000 | 1,800,000 | 24,600,000 | -8,700,000 | -900,000 | 119,500,000 | ||||||||||||||||
other accruals and liabilities | 122,800,000 | 11,600,000 | -223,200,000 | 120,300,000 | 105,300,000 | 51,300,000 | -173,500,000 | 103,300,000 | 51,300,000 | 14,700,000 | -191,400,000 | -169,400,000 | 24,000,000 | |||||||||||||||||||
net operating activities | 258,800,000 | 135,200,000 | 2,800,000 | 247,300,000 | 228,500,000 | 223,800,000 | -5,000,000 | 161,500,000 | 216,900,000 | 171,400,000 | -108,200,000 | -34,700,000 | 243,300,000 | 246,600,000 | 119,200,000 | 61,700,000 | 156,600,000 | |||||||||||||||
investing activities: | ||||||||||||||||||||||||||||||||
purchases of: | ||||||||||||||||||||||||||||||||
investments | 26,200,000 | -121,600,000 | -44,800,000 | 57,200,000 | -52,000,000 | -32,300,000 | -9,900,000 | -11,200,000 | 30,700,000 | |||||||||||||||||||||||
property, equipment and software | -2,400,000 | -2,000,000 | -1,900,000 | -3,800,000 | -2,600,000 | -1,900,000 | -1,800,000 | -2,400,000 | -1,900,000 | -4,500,000 | -2,000,000 | -7,500,000 | ||||||||||||||||||||
investments by consolidated seeded investment products | 50,400,000 | -126,000,000 | -181,700,000 | 77,600,000 | -114,900,000 | -26,000,000 | -38,100,000 | -55,100,000 | -6,800,000 | |||||||||||||||||||||||
seed capital hedges | ||||||||||||||||||||||||||||||||
acquisitions, net of cash acquired | -1,100,000 | -1,800,000 | -2,400,000 | -109,700,000 | ||||||||||||||||||||||||||||
net investing activities | 39,400,000 | -290,800,000 | -227,300,000 | 44,300,000 | -215,000,000 | -60,400,000 | -54,300,000 | -86,800,000 | 16,000,000 | -23,000,000 | -235,100,000 | 51,300,000 | 13,000,000 | 31,900,000 | 44,400,000 | 11,600,000 | -45,300,000 | |||||||||||||||
financing activities: | ||||||||||||||||||||||||||||||||
purchase of common stock for stock-based compensation plans | -400,000 | -93,800,000 | -2,600,000 | 200,000 | 400,000 | -10,500,000 | -69,900,000 | -100,000 | 200,000 | 0 | -57,500,000 | -37,100,000 | ||||||||||||||||||||
purchase of common stock for the share buyback program | -66,500,000 | -49,500,000 | -26,800,000 | -53,100,000 | -39,700,000 | -34,100,000 | -81,300,000 | |||||||||||||||||||||||||
dividends paid to shareholders | -62,400,000 | -63,800,000 | -61,500,000 | -62,000,000 | -62,300,000 | -62,600,000 | -63,200,000 | -64,700,000 | -64,700,000 | -64,600,000 | -64,700,000 | -69,700,000 | ||||||||||||||||||||
issuance of long-term debt | -1,300,000 | |||||||||||||||||||||||||||||||
third-party capital invested into consolidated seeded investment products | -33,400,000 | 134,700,000 | 170,600,000 | -98,700,000 | 130,500,000 | 56,100,000 | 35,200,000 | |||||||||||||||||||||||||
net financing activities | -163,200,000 | -67,700,000 | 79,600,000 | -518,900,000 | 424,600,000 | -50,900,000 | -179,200,000 | -76,100,000 | -91,500,000 | 1,900,000 | 13,800,000 | -198,300,000 | ||||||||||||||||||||
cash and cash equivalents: | ||||||||||||||||||||||||||||||||
effect of foreign exchange rate changes | -5,900,000 | 29,400,000 | 15,800,000 | -42,700,000 | 31,900,000 | 0 | -7,300,000 | 29,200,000 | -25,500,000 | 11,800,000 | 15,400,000 | 5,000,000 | 6,100,000 | -2,000,000 | ||||||||||||||||||
net change | 129,100,000 | -193,900,000 | -129,100,000 | -270,000,000 | 470,000,000 | 112,500,000 | -245,800,000 | 27,800,000 | 115,900,000 | 162,100,000 | -314,100,000 | -176,700,000 | 120,500,000 | 16,000,000 | ||||||||||||||||||
at beginning of period | 0 | 0 | 1,234,800,000 | 0 | 0 | 0 | 1,168,100,000 | 0 | 0 | 0 | 1,176,400,000 | 916,600,000 | 0 | 0 | 794,200,000 | 0 | ||||||||||||||||
at end of period | 129,100,000 | -193,900,000 | 1,105,700,000 | -270,000,000 | 470,000,000 | 112,500,000 | 922,300,000 | 27,800,000 | 115,900,000 | 162,100,000 | 862,300,000 | 1,176,398,964.3 | 162 | 60.3 | 813.4 | 1,118,599,055.4 | -32.7 | 140.7 | 836.6 | 1,108,099,073.5 | 46.1 | 78.2 | 802.2 | 796,499,226.3 | 42.7 | -739,899,269 | 739,900,000 | 92,300,000 | 38,400,000 | 665,400,000 | 16,000,000 | |
supplemental cash flow information: | ||||||||||||||||||||||||||||||||
cash paid for interest | 10,900,000 | 0 | 10,900,000 | 3,900,000 | 7,300,000 | 0 | 7,300,000 | 0 | 7,300,000 | 0 | 7,300,000 | 14,599,985.4 | 7.3 | 0 | 7.3 | 14,599,985.4 | 7.3 | 0 | 7.3 | 14,599,985.4 | 7.3 | 0 | 7.3 | 14,599,985.4 | 7.3 | -7,299,992.7 | 7,300,000 | 0 | 7,400,000 | 0 | 7,400,000 | 7,700,000 |
cash paid for income taxes, net of refunds | 37,200,000 | 88,000,000 | 3,500,000 | 38,300,000 | 39,100,000 | 49,700,000 | 6,200,000 | 25,200,000 | 23,100,000 | 41,900,000 | 14,100,000 | 140,699,877.9 | 29.3 | 74.4 | 18.4 | 217,599,830.8 | 56.1 | 104 | 9.1 | 158,999,869.4 | 97.7 | 28 | 4.9 | 159,999,856.3 | 29 | -12,599,885.3 | 12,600,000 | 40,800,000 | 39,000,000 | 78,500,000 | 26,400,000 | 30,700,000 |
reconciliation of cash and cash equivalents: | ||||||||||||||||||||||||||||||||
cash and cash equivalents | 114,300,000 | -201,000,000 | 1,083,600,000 | -266,600,000 | 469,900,000 | 109,200,000 | 904,700,000 | 31,200,000 | 124,300,000 | 153,400,000 | 843,500,000 | 1,162,298,977.1 | 159.8 | 62.3 | 800.8 | 1,107,299,066.9 | -33.8 | 140.8 | 826.1 | 1,099,699,091 | 72.4 | 104.1 | 732.5 | 733,899,263.7 | 29.3 | -717,099,293 | 717,100,000 | 125,600,000 | 85,000,000 | 58,400,000 | 611,400,000 | 10,100,000 |
cash and cash equivalents held in consolidated vies | 14,800,000 | 7,100,000 | 22,100,000 | -3,400,000 | 100,000 | 3,300,000 | 17,600,000 | -3,400,000 | -8,400,000 | 8,700,000 | 18,800,000 | 22,800,000 | -5,100,000 | 7,300,000 | -20,000,000 | 54,000,000 | ||||||||||||||||
total cash and cash equivalents | 129,100,000 | -193,900,000 | 1,105,700,000 | -270,000,000 | 470,000,000 | 112,500,000 | 922,300,000 | 27,800,000 | 115,900,000 | 162,100,000 | 862,300,000 | 1,176,398,964.3 | 162 | 60.3 | 813.4 | 1,118,599,055.4 | -32.7 | 140.7 | 836.6 | 1,108,099,073.5 | 46.1 | 78.2 | 802.2 | 796,499,226.3 | 42.7 | -739,899,269 | 739,900,000 | 120,500,000 | 92,300,000 | 38,400,000 | 665,400,000 | 16,000,000 |
cash paid on settled seed capital hedges | -28,300,000 | -200,000 | -5,200,000 | |||||||||||||||||||||||||||||
investment losses (gains) | 5,500,000 | -24,800,000 | 5,900,000 | -6,900,000 | -17,600,000 | |||||||||||||||||||||||||||
cash received (paid) on settled seed capital hedges | 2,600,000 | -22,200,000 | -6,000,000 | -6,200,000 | -3,100,000 | |||||||||||||||||||||||||||
impairment of intangible assets | ||||||||||||||||||||||||||||||||
loss on sale of intech | ||||||||||||||||||||||||||||||||
benefit from credit losses and contingent consideration adjustments | -1,600,000 | |||||||||||||||||||||||||||||||
sales (purchases) of: | ||||||||||||||||||||||||||||||||
long-term note with intech | 4,100,000 | 0 | ||||||||||||||||||||||||||||||
proceeds from sale of subsidiaries | ||||||||||||||||||||||||||||||||
repayment of current portion of long-term debt | ||||||||||||||||||||||||||||||||
reclassification adjustment for foreign currency translation gain included in net income | -22,000,000 | |||||||||||||||||||||||||||||||
contributions to pension plans in excess of costs recognized | -600,000 | -2,100,000 | -400,000 | -500,000 | -400,000 | -1,800,000 | ||||||||||||||||||||||||||
dividends received from equity method investments | 700,000 | 0 | ||||||||||||||||||||||||||||||
principal payments under capital lease obligations | 0 | 0 | -200,000 | -200,000 | -300,000 | |||||||||||||||||||||||||||
dividends received from equity-method investments | 700,000 | 500,000 | ||||||||||||||||||||||||||||||
receipt of contingent consideration payments from sale of subsidiaries | 0 | 0 | ||||||||||||||||||||||||||||||
proceeds from stock-based compensation plans | 500,000 | 200,000 | 8,200,000 | 100,000 | 100,000 | 200,000 | 300,000 | |||||||||||||||||||||||||
purchase of common stock for the share buyback program and from dai-ichi life | ||||||||||||||||||||||||||||||||
revolving credit facility issuance costs | 0 | -100,000 | ||||||||||||||||||||||||||||||
distributions to noncontrolling interests | -100,000 | |||||||||||||||||||||||||||||||
proceeds from sale of intech | ||||||||||||||||||||||||||||||||
purchase of common stock for share buyback program | -30,900,000 | |||||||||||||||||||||||||||||||
third-party sales (purchases) in consolidated seeded investment products | -27,100,000 | 65,400,000 | 136,200,000 | |||||||||||||||||||||||||||||
investment securities | -107,500,000 | 19,300,000 | -3,000,000 | -5,800,000 | ||||||||||||||||||||||||||||
investment securities by consolidated seeded investment products | -123,200,000 | 46,100,000 | 10,900,000 | |||||||||||||||||||||||||||||
impairment of goodwill and intangible assets | ||||||||||||||||||||||||||||||||
impairment of right-of-use operating asset | ||||||||||||||||||||||||||||||||
(gain) loss on sale of subsidiaries | ||||||||||||||||||||||||||||||||
investment (gains) losses | -13,300,000 | |||||||||||||||||||||||||||||||
contingent consideration fair value adjustment | ||||||||||||||||||||||||||||||||
purchase of common stock from dai-ichi life and share buyback program | ||||||||||||||||||||||||||||||||
payment of contingent consideration | -14,100,000 | |||||||||||||||||||||||||||||||
jhg long-term note with intech | ||||||||||||||||||||||||||||||||
gain on sale of geneva | ||||||||||||||||||||||||||||||||
receipt of contingent consideration payments from sale of volantis | ||||||||||||||||||||||||||||||||
receipt of contingent consideration payments from sale of geneva | ||||||||||||||||||||||||||||||||
proceeds from sale of geneva | ||||||||||||||||||||||||||||||||
third-party sales in consolidated seeded investment products | ||||||||||||||||||||||||||||||||
gain from bnp paribas transaction | ||||||||||||||||||||||||||||||||
dai-ichi option fair value adjustments | ||||||||||||||||||||||||||||||||
proceeds from bnp paribas transaction | 0 | 0 | ||||||||||||||||||||||||||||||
repayment of long-term debt | ||||||||||||||||||||||||||||||||
third-party sales (redemptions) in consolidated seeded investment products | -46,100,000 | -21,700,000 | 38,400,000 | |||||||||||||||||||||||||||||
contingent consideration adjustment | ||||||||||||||||||||||||||||||||
proceeds from | ||||||||||||||||||||||||||||||||
contingent consideration from sale of volantis | ||||||||||||||||||||||||||||||||
contingent consideration from sale of geneva | ||||||||||||||||||||||||||||||||
cash received (paid) on settled hedges | -7,400,000 | |||||||||||||||||||||||||||||||
proceeds from sale of volantis | 300,000 | 1,600,000 | ||||||||||||||||||||||||||||||
impairment of intangible asset | ||||||||||||||||||||||||||||||||
gains from equity-method investments | ||||||||||||||||||||||||||||||||
impairment of rou operating asset | 4,700,000 | |||||||||||||||||||||||||||||||
cash acquired from acquisition of jcg | ||||||||||||||||||||||||||||||||
investment income received by consolidated funds | ||||||||||||||||||||||||||||||||
cash movement on deconsolidation of consolidated funds | ||||||||||||||||||||||||||||||||
dividends attributable to noncontrolling interests | ||||||||||||||||||||||||||||||||
settlement of convertible note hedge | ||||||||||||||||||||||||||||||||
settlement of stock warrant | ||||||||||||||||||||||||||||||||
proceeds from issuance of options | ||||||||||||||||||||||||||||||||
at beginning of year | ||||||||||||||||||||||||||||||||
at end of year | ||||||||||||||||||||||||||||||||
cash acquired from acquisition | 0 | |||||||||||||||||||||||||||||||
net cash received (paid) on settled hedges | -2,600,000 | |||||||||||||||||||||||||||||||
proceeds from settlement of convertible note hedge | 0 | |||||||||||||||||||||||||||||||
proceeds from issuance of option | ||||||||||||||||||||||||||||||||
third-party redemptions in consolidated seeded investment products | ||||||||||||||||||||||||||||||||
reconciliation of cash and cash equivalents | ||||||||||||||||||||||||||||||||
losses from equity-method investments | ||||||||||||||||||||||||||||||||
gain from bnp transaction | ||||||||||||||||||||||||||||||||
proceeds from bnp transaction | 36,500,000 | |||||||||||||||||||||||||||||||
net cash paid on settled hedges | 2,900,000 | |||||||||||||||||||||||||||||||
proceeds from: | ||||||||||||||||||||||||||||||||
investment securities - vies | -37,300,000 | |||||||||||||||||||||||||||||||
investment securities - seed capital | 1,000,000 | |||||||||||||||||||||||||||||||
stock-based compensation expense | ||||||||||||||||||||||||||||||||
impairment of equity-method investment | ||||||||||||||||||||||||||||||||
repayment of long-term borrowings | ||||||||||||||||||||||||||||||||
cash and cash equivalents held in vies |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
